225.6K XNYS Volume
XNYS 24 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Adam Savitz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 76,000 | 76,000 | - | - | Employee Stock Option (Right to Buy) | |
| Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 135,000 | 135,000 | - | - | Employee Stock Option (Right to Buy) | |
| Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 215,000 | 215,000 | - | - | Employee Stock Option (Right to Buy) | |
| Michael Conick Hanley | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) | |
| Husseini Manji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 14,195 | 14,195 | - | - | Stock Option (right to buy) | |
| Christopher Nixon Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 25,236 | 25,236 | - | - | Stock Option (right to buy) | |
| Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 19,558 | 19,558 | - | - | Stock Option (right to buy) | |
| Adam Savitz | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 12.53 per share. | 09 Jul 2024 | 10,681 | 35,532 | - | 12.5 | 133,833 | Common Stock |
| Adam Savitz | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 13.22 per share. | 09 Jul 2024 | 2,931 | 39,851 | - | 13.2 | 38,748 | Common Stock |
| Adam Savitz | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 13.15 per share. | 09 Jul 2024 | 1,388 | 36,920 | - | 13.1 | 18,252 | Common Stock |
| Michael Conick Hanley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 188,000 | 188,000 | - | - | Employee Stock Option (right to buy) | |
| Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 16.56 per share. | 28 Mar 2024 | 4,550 | 26,866 | - | 16.6 | 75,348 | Common Stock |
| Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 15.80 per share. | 28 Mar 2024 | 1,600 | 22,316 | - | 15.8 | 25,280 | Common Stock |
| Mahalakshmi Radhakrishnan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 1,590 | 1,590 | - | - | Stock Option (right to buy) | |
| Mahalakshmi Radhakrishnan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 30,574 | 30,574 | - | - | Stock Option (right to buy) | |
| Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 34,711 | 1,240,176 | - | 0 | Common Stock | |
| Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 223,000 | 223,000 | - | - | Employee Stock Option (Right to Buy) | |
| Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
| Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 19,153 | 20,716 | - | 0 | Common Stock | |
| Adam Savitz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 73,000 | 73,000 | - | - | Employee Stock Option (Right to Buy) | |
| Po Yu Chen | Director | 06 Feb 2024 | 8,450 | 47,709 | - | - | Common Stock | ||
| Gwill York | Director | 06 Feb 2024 | 23,917 | 23,917 | - | - | Common Stock | ||
| Gwill York | Director | 06 Feb 2024 | 53,196 | 0 | - | - | Series A Preferred Stock | ||
| Amit Etkin | Director, PRESIDENT AND CEO | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Feb 2024 | 3,125 | 1,205,465 | - | 16 | 50,000 | Common Stock |
| Amit Etkin | Director, PRESIDENT AND CEO | 06 Feb 2024 | 11,777 | 1,202,340 | - | - | Common Stock | ||
| Amit Etkin | Director, PRESIDENT AND CEO | 06 Feb 2024 | 25,000 | 0 | - | - | Series B Preferred Stock | ||
| Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Feb 2024 | 1,563 | 1,563 | - | 16 | 25,008 | Common Stock |
| Adam Savitz | CHIEF MEDICAL OFFICER | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Feb 2024 | 17,000 | 24,851 | - | 16 | 272,000 | Common Stock |
| Adam Savitz | CHIEF MEDICAL OFFICER | 06 Feb 2024 | 16,666 | 0 | - | - | Series B Preferred Stock | ||
| Adam Savitz | CHIEF MEDICAL OFFICER | 06 Feb 2024 | 7,851 | 7,851 | - | - | Common Stock | ||
| Po Yu Chen | Director | 06 Feb 2024 | 83,333 | 0 | - | - | Series B Preferred Stock | ||
| Po Yu Chen | Director | 06 Feb 2024 | 39,259 | 39,259 | - | - | Common Stock | ||
| Christopher Nixon Cox | Director | 06 Feb 2024 | 1,250,000 | 0 | - | - | Series B Preferred Stock | ||
| Christopher Nixon Cox | Director | 06 Feb 2024 | 126,755 | 715,653 | - | - | Common Stock | ||
| Christopher Nixon Cox | Director | 06 Feb 2024 | 588,898 | 588,898 | - | - | Common Stock | ||
| Christopher Nixon Cox | Director | 06 Feb 2024 | 281,917 | 0 | - | - | Series C Preferred Stock | ||
| Po Yu Chen | Director | 06 Feb 2024 | 18,794 | 0 | - | - | Series C Preferred Stock | ||
| Husseini Manji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 30,574 | 30,574 | - | - | Stock Option (right to buy) | |
| Husseini Manji | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 3,083 | 3,083 | - | - | Stock Option (right to buy) | |
| Christopher Nixon Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,623 | 4,623 | - | - | Stock Option (right to buy) | |
| Christopher Nixon Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 30,574 | 30,574 | - | - | Stock Option (right to buy) | |
| Po Yu Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 30,574 | 30,574 | - | - | Stock Option (right to buy) | |
| Po Yu Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 1,540 | 1,540 | - | - | Stock Option (right to buy) | |
| Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 30,574 | 30,574 | - | - | Stock Option (right to buy) | |
| Gwill York | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 3,083 | 3,083 | - | - | Stock Option (right to buy) | |
| Andrew Dreyfus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 30,574 | 30,574 | - | - | Stock Option (right to buy) |